Inspirato Inc Expected To Post A Loss Of $1.72 A Share - Earnings

Xponential Fitness came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.19. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -115.79%. A quarter ago, it was expected that this franchisor of boutique fitness brands would post earnings of $0.18 per share when it actually produced earnings of $0.16, delivering a surprise of -11.11%.

Over the last four quarters, the company has surpassed consensus EPS estimates just once.

Xponential Fitness, which belongs to the Zacks Leisure and Recreation Services industry, posted revenues of $76.52 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 8.84%. This compares to year-ago revenues of $77.34 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Xponential Fitness shares have added about 33.2% since the beginning of the year versus the S&P 500's gain of 15.8%.

What's Next for Xponential Fitness?

While Xponential Fitness has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Xponential Fitness: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.22 on $86.63 million in revenues for the coming quarter and $0.95 on $345.47 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Leisure and Recreation Services is currently in the bottom 20% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Inspirato Incorporated , has yet to report results for the quarter ended June 2024.

This company is expected to post quarterly loss of $2.05 per share in its upcoming report, which represents a year-over-year change of -213.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Inspirato Incorporated's revenues are expected to be $69.94 million, down 16.8% from the year-ago quarter.

Zacks Investment Research

Shares of Merck & Co., Inc. fell sharply during Tuesday's session after the company reported second-quarter financial results and cut its FY24 adjusted EPS guidance below estimates.

Merck reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15, according to data from Benzinga Pro.

Merck shares dipped 9.5% to $115.50 on Tuesday.

Here are some other stocks moving in today’s mid-day session.

Gainers

• Imunon, Inc. shares jumped 147.8% to $2.9250 after the company announced topline results from its Phase 2 OVATION 2 study with IMNN-001. The results showed an 11.1-month improvement in median overall survival compared to standard-of-care alone in the intent-to-treat population.
• Agape ATP Corporation surged 97% to $0.1731. AGAPE ATP strengthened wellness division via innovative incubation with emerging local SMEs.
• Processa Pharmaceuticals, Inc. shares climbed 53% to $2.60 after the company announced FDA clearance of its IND application for a Phase 2 clinical trial of NGC-Cap in breast cancer.
• INVO Bioscience, Inc. gained 33% to $1.1513.
• Jet.AI Inc. shares gained 29% to $0.3850.
• 2U, Inc. jumped 28% to $3.4018.
• CalciMedica, Inc. jumped 26.3% to $5.24.
• JetBlue Airways Corporation rose 20.6% to $7.16 after the company reported better-than-expected second-quarter financial results.
• Lumen Technologies, Inc. rose 19.1% to $2.3050.
• Commvault Systems, Inc. gained 19.1% to $146.77 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY25 revenue guidance.
• Harmonic Inc. climbed 18.8% to $13.96 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.
• Meta Data Limited gained 18.8% to $5.42.
• Enveric Biosciences, Inc. rose 18.3% to $0.59 after jumping around 6% on Monday.
• Inspirato Incorporated gained 18.3% to $6.20 after jumping over 50% on Monday.
• Sprouts Farmers Market, Inc. shares gained 15.9% to $98.13 after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.
• NeoGenomics, Inc. gained 16.1% to $17.00 following upbeat earnings.
• Tilray Brands, Inc. rose 16.1% to $2.1250 after the company reported better-than-expected quarterly financial results.
• Sprouts Farmers Market, Inc. gained 15.5% to $97.79 after the company reported better-than-expected second-quarter financial results. Additionally, the company issued third-quarter earnings guidance above estimates.
• Howmet Aerospace Inc. climbed 14.1% to $94.56 following better-than-expected second-quarter earnings, issued strong guidance, raised its dividend, increased its buyback authorization and issued strong guidance.
• Repligen Corporation gained 13.4% to $156.48 following -quarter earnings.
• Varonis Systems, Inc. climbed 13.3% to $54.92 as the company reported better-than-expected second-quarter financial results and raised its FY24 guidance on Monday.
• Hayward Holdings, Inc. gained 11% to $14.98 after the company reported better-than-expected second-quarter EPS results.
• F5, Inc. shares rose 10.6% to $196.46 after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.
• Pharming Group N.V. shares gained 9.8% to $8.28. Pharming Group will report second quarter financial results on Aug. 1.
• PayPal Holdings, Inc. climbed 8.5% to $63.98 after the company reported better-than-expected second quarter financial results.
• Stanley Black & Decker, Inc. rose 8.1% to $104.28 after the company reported better-than-expected second quarter financial results. Additionally, the company revised its FY24 adjusted EPS forecast upward.
• Gartner, Inc. gained 6.4% to $500.83 following better-than-expected quarterly earnings.

Losers

• QXO, Inc. Q shares fell 80.8% to $11.44. This sudden decline was triggered by the registration of two private placements with the U.S. Securities and Exchange Commission, which unlocked millions of shares and led to increased selling pressure, Bloomberg reported on Tuesday.
• VBI Vaccines Inc. declined 64.8% to $0.1960 after the company was granted protection under Canada’s CCAA by the Ontario Superior Court. The company received approval for a DIP loan, and Ernst & Young was appointed as the monitor during the restructuring process.
• CNS Pharmaceuticals, Inc. C dipped 40.8% to $0.6158 after the company announced it entered into an exclusive license agreement with Cortice Biosciences.
• BIMI Holdings Inc. tumbled 37% to $0.73.
• Bloomz Inc. B dipped 30.7% to $1.78.
• Ekso Bionics Holdings, Inc. fell 26.6% to $1.0901 after the company reported worse-than-expected quarterly sales results.
• Novavax, Inc. shares declined 25.2% to $12.27 after declining 4% on Monday.
• VSee Health, Inc. V fell 23.3% to $2.7999.
• SmartRent, Inc. dipped 21.5% to $1.8850 after the company announced a CEO resignation and suspended its 2024 outlook.
• Symbotic Inc. shares fell 21.1% to $28.13 after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.
• Woodward, Inc. fell 16.5% to $152.91 after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.
• NIP Group Inc. N fell 16.2% to $13.82. NIP Group announced the closing of its initial public offering and partial exercise of underwriters' option to purchase additional ADSs.
• Merchants Bancorp dipped 16.2% to $43.68 after the company reported worse-than-expected quarterly financial results. Additionally, Raymond James downgraded the stock.
• Amkor Technology, Inc. shares fell 14.2% to $32.24 after the company issued roughly in-line guidance.
• OneWater Marine Inc. dipped 13.2% to $26.43 after the company reported worse-than-expected third-quarter financial results and issued weak guidance.
• Celldex Therapeutics, Inc. shares fell 11.6% to $37.06 after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.
• Transcat, Inc. declined 11.2% to $120.00 following weak quarterly sales.
• CrowdStrike Holdings, Inc. dipped 9.7% to $233.65 following reports indicating Delta Air Lines would seek compensation from the cybersecurity company for last week’s outage.
• Rambus Inc. shares dipped 9.3% to $50.61 following weak quarterly sales.
• Corning Incorporated fell 8.7% to $38.99 following second-quarter results.
• Lattice Semiconductor Corporation shares fell 8.3% to $50.40 after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.
• Ecolab Inc. declined 6.7% to $231.31 after the company reported worse-than-expected second-quarter sales results.
• The Procter & Gamble Company fell 6.2% to $159.37 following a quarterly revenue miss.
• Diageo plc fell 5.5% to $124.30 after the company missed annual profit expectations.
• Fresenius Medical Care AG shares declined 4.5% to $19.45 following weak quarterly sales.

Now Read This:

• Top 3 Health Care Stocks You May Want To Dump This Quarter

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!

Moving stocks this morning are earnings reports, clinical trial results and more.

Let’s get into that news below!

Biggest Pre-Market Stock Movers: 10 Top Gainers

• Imunon stock is rocketing more than 133% alongside Phase 2 clinical trial results.
• Jet AI shares are soaring over 57% despite a lack of news this morning.
• Enveric Biosciences stock is surging more than 32% with strong early morning trading.
• Inspirato shares are rising close to 26% without any clear news this morning.
• Pharming stock is heading over 21% higher ahead of its upcoming earnings report.
• Sprouts Farmers Market shares are increasing more than 17% after releasing its Q2 earnings.
• Harmonic stock is climbing over 17% with its Q2 earnings report.
• Davis Commodities shares are gaining more than 15% on Tuesday morning.
• T2 Biosystems stock is getting an over 14% boost with its latest earnings report.
• Serve Robotics shares are up more than 14% after announcing investor meeting plans.

10 Top Losers

• QXO Q stock is crashing over 80% after announcing a private placement.
• BIMI shares are plummeting more than 23% on Tuesday morning.
• Ekso Bionics stock is diving over 22% alongside its Q2 earnings results.
• Symbotic shares are tumbling more than 18% after reporting a Q3 loss.
• Lattice Semiconductor stock is taking an almost 18% beating with its latest earnings report.
• Lipella Pharmaceuticals shares are falling over 17% after a rally yesterday.
• Cognition Therapeutics stock is dropping more than 16% as it continues downward movement on study results.
• NLS Pharmaceutics shares are sliding over 14% following a merger rally yesterday.
• Troops stock is decreasing more than 13% today.
• Loop Media shares close out our pre-market stock movers down over 12% after jumping yesterday on a new partnership.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

More from InvestorPlace

• Why I’m Betting on Green Hydrogen’s Slow-Motion Revolution
• Why Tech Stocks Are Poised for a Strong Comeback Now
• Why CrowdStrike Is a Great Buy… Despite Its Recent Software Snafu

Shares of F5, Inc. shares rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.

F5 reported quarterly earnings of $3.36 per share, which beat the analyst consensus estimate of $2.97 per share. Quarterly sales came in at $695.495 million, which beat the analyst consensus estimate of $686.062 million, according to data from Benzinga Pro.

F5 shares jumped 14.3% to $202.92 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Imunon, Inc. gained 104.2% to $2.41 in pre-market trading. IMUNON will report topline results from the Phase 2 OVATION 2 study with IMNN-001 In advanced ovarian cancer on July 30.
• Jet.AI Inc. shares climbed 48% to $0.4422 in pre-market trading.
• Enveric Biosciences, Inc. rose 26.3% to $0.6289 in pre-market trading after jumping around 6% on Monday.
• Inspirato Incorporated gained 22.3% to $6.41 in pre-market trading after jumping over 50% on Monday.
• Sprouts Farmers Market, Inc. shares gained 17.4% to $99.50 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.
• Serve Robotics Inc. gained 16.1% to $22.51 in pre-market trading after jumping 47% on Monday.
• NIP Group Inc. N shares gained 15.2% to $19.00 in pre-market trading. NIP Group announced the closing of its initial public offering and partial exercise of underwriters’ option to purchase additional ADSs.
• Pharming Group N.V. shares gained 10.1% to $8.30 in pre-market trading. Pharming Group will report second quarter financial results on Aug. 1.
• Nomura Holdings, Inc. gained 8.2% to $6.33 in pre-market trading.

Losers

• QXO, Inc. Q shares fell 79.9% to $12.00 in pre-market trading after dipping 23% on Monday.
• Symbotic Inc. shares declined 19.5% to $28.70 in pre-market trading after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.
• Lattice Semiconductor Corporation shares fell 14.8% to $46.82 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.
• TROOPS, Inc. shares fell 13.2% to $3.22 in pre-market trading.
• Woodward, Inc. fell 10.5% to $164.01 in pre-market trading after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.
• Novavax, Inc. shares declined 9.6% to $14.85 in pre-market trading after declining 4% on Monday.
• Celldex Therapeutics, Inc. shares fell 8.6% to $38.33 in pre-market trading after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.
• Diageo plc fell 8.5% to $120.36 in pre-market trading after the company missed annual profit expectations.
• Rambus Inc. shares dipped 7.8% to $51.50 in pre-market trading following weak quarterly sales.
• Amkor Technology, Inc. shares fell 6.2% to $35.28 in pre-market trading after the company issued roughly in-line guidance.

Now Read This:

• Roblox, Morgan Stanley And 2 Other Stocks Insiders Are Selling

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Inspirato just reported results for the first quarter of 2024.

• Inspirato reported earnings per share of -18 cents.
• The company reported revenue of $80.25 million.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

More from InvestorPlace

• Strong Earnings: Just Another Reason to Buy AI Stocks
• Insider Buying Isn’t Enough: Why Intel Stock’s Comeback Remains Uncertain
• Wedbush Sounds a Palantir (PLTR) Stock Alarm on ‘Golden Opportunity’ to Buy Shares